Langerhans cell histiocytosis (LCH), a rare disorder of unknown cause affecting both children and adults, can involve many different organs and present to a wide range of medical specialties. LCH is now regarded as a 'reactive' disorder in which cells bearing the Langerhans cell phenotype accumulate and/or proliferate in physiologically normal and abnormal sites.' 2 The subsequent local tissue damage may cause organ dysfunction and in severe cases, death. The tissue destruction in LCH is believed to be at least partly the result of excess cytokine production. 3 The Langerhans cells in normal skin from our patient showed normal functional activity. This finding suggests that the defective functional characteristic of LCH cells is localised to these cells and does not involve the entire Langerhans cell population. The significance of the increased functional activity of Langerhans cells overlying the involved dermal infiltrate is unclear but it is possible that cytokines generated in the underlying dermal infiltrate activate the overlying Langerhans cells. The profound restrictions on work in this disease due to the difficulties in obtaining fresh viable tissues make this study unique. Further studies will concentrate on purifying LCH cells in order that the present results can be validated. The results of this study do, however, strongly suggest that LCH is a disease in which functionally abnormal Langerhans cells accumulate and/or proliferate in various tissues but the abnormality seems to be confined to the lesional LCH cells.
